Australia's Qantas obtains court order to prevent third-party access to stolen data
Earlier this month, a cyber hacker broke into a database containing the personal information of millions of Qantas customers, Australia's biggest such breach in years. Similar incidents took place in 2022, with telecommunications giant Optus and health insurer Medibank.
There continues to be no evidence that any personal data stolen from Qantas has been released, the company said in the statement.
The country's flag carrier said that last week it had contacted the 5.7 million affected customers, outlining the specific fields of their personal data that were compromised.
"No credit card details, personal financial information or passport details were stored in the compromised system and therefore have not been accessed," Qantas said.
The airline operator said it is working closely with several bodies, such as the Australian Federal Police, the National Cyber Security Coordinator and the Australian Cyber Security Centre, to thoroughly investigate criminal activity surrounding the breach.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
Matching Occupational Exoskeletons With The Right Work Task
Regardless of whether one thinks of industrial exoskeletons as personal protective equipment (PPE), an engineering solution, or something in between, these wearable devices are still an ergonomic solution that needs to be applied to the correct problem. In the decade that this technology has started to see an ever-growing adoption at work sites, the responsibility of matching the exoskeleton with a job task continues to fall on the end user or buyer. This is a persistent hurdle towards mass adoption, with several solutions on the horizon. How it started: Like any new technology, exoskeleton startups had no choice but to sell their products directly. This meant that if a company wanted to select and compare devices, it had to discover each one and establish unique communication channels. This process can be slow and laborious, and the lessons learned by one buyer are often not shared with others. One exception that exists in the public domain is 'The implementation of cobotics and exoskeletal devices for the Australia red meat processing industry,' a 91-page report published by AMPC comparing 19 industrial exoskeletons. Ten years later, the landscape has gone through some dramatic changes. Multiple standards bodies have looked into classifying and evaluating occupational exoskeletons. Fraunhofer IPA, a leading German research institute, has created a series of parcours to evaluate occupational exoskeletons as product families grouping results by task. Another change is the emergence of distributors, which could either be dedicated to one supplier or carry multiple products from different developers. As a quick note, choosing the correct exoskeleton solution (or deciding if a wearable is even the correct solution) for a repetitive work task is just one piece of the puzzle for a successful implementation. Still, it is often the first step in the process, and an error there will cascade down through pilots and long-term adoption efforts (and will most certainly negatively impact any return business). Even with all these changes, the majority of occupational exoskeletons are still sold directly by their producers, with some alternative acquisition and comparison pathways emerging: First, several dedicated consulting companies have sprouted in North America and Europe, which can provide support in choosing the right exoskeleton system for a fee. Second, some distributors carry devices from multiple developers, and their sales team is becoming more experienced with the strengths of each one. Third, some companies go beyond the role of a distributor and have become closer to an integrator that goes on a journey with the end user and buyers, helping them through the entire process of selection, comparison, and setting up a pilot. Last but not least, in the age of AI and digital tools, there have been multiple systems proposed that can collect data from repetitive work tasks, and some are designed specifically for wearables. The challenge with this digital solution is data collection, which can range from cell phone videos to motion tracking or even full EMG studies, but that is not all, because in addition to data collection, data interpretation with these systems is not trivial and requires effort before it can be condensed and summarized into a digestible report. How could things shape up in the future? There are a few likely scenarios on how the complexity of selecting an occupational exoskeleton could be reduced while creating a more positive and streamlined experience for decision makers and buyers. The car dealership route - developers of occupational exoskeletons could continue to consolidate so that each one has a full portfolio. This would be similar to shopping for a car, where car company A would offer sedans through trucks and everything in between, and the dealership next to it would offer the same range of vehicle classes from a different maker. An alternative to that would be an increase in multi-vendor distributors that already carry competing brands. Some examples of this happening right now would be Stanley Handling and FoxInnovation in Europe, The Exoskeleton Store and ExxoVantage in the Americas and Oceania. With this model, buyers have to visit fewer places and can also leverage the experience of the multi-vendor distributors to assist with selection. The final version could be an investment and improvement in digital tools. This could include online comparison tools, such as those found on car or camera equipment websites, or something more custom that can collect and interpret data from job sites and compare it against the known capabilities of different types and brands of industrial exoskeletons. All this work will lead to the formation of a marketplace, allowing buyers and end users to compare and evaluate industrial wearable solutions against data or prior knowledge. This would simplify the buying process considerably and lower the entry barrier for professionals and companies interested in becoming early adopters of wearable devices that provide direct physical support for their jobs.
Yahoo
2 hours ago
- Yahoo
VB Spine Launches in Australia and New Zealand
Stryker's spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor NEW YORK & SYDNEY, July 31, 2025--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), a global, family-led spine company dedicated to advancing patient outcomes, announced the completion of the sale of Stryker's spinal implants business in Australia and New Zealand. This milestone builds upon the formation of VB Spine on April 1, 2025, following the acquisition of Stryker's U.S. spinal implants business by Viscogliosi Brothers, LLC. It also marks VB Spine's first market entry outside the United States and establishes a direct presence in two fast-growing markets. VB Spine continues to have exclusive access to Stryker's Mako Spine and the Copilot automatic depth stop feature. This strategic partnership creates a strong foundation for VB Spine's continued growth, providing surgeons greater precision and improving patient outcomes. "From the start, our vision has been simple: put patients first and innovate boldly," said Marc Viscogliosi, co-CEO of VB Spine, speaking for his brothers and fellow co-CEOs Anthony and John Viscogliosi. "Today we take that vision global. By combining the passion of our family-run culture with LifeHealthcare's best-in-class surgeon support, we're opening a new chapter in spine care defined by access, outcomes, and possibility." LifeHealthcare, already the long-standing distributor for these products, will continue as the exclusive partner, providing uninterrupted product availability and clinical support for surgeons and their patients throughout Australia and New Zealand. Paul Petherbridge, CEO of LifeHealthcare, said, "We are pleased to announce our long-term collaboration with VB Spine. LifeHealthcare has represented this portfolio since 2010, providing clinicians and patients in Australia and New Zealand with reliable access to spinal instrumentation and implants through our experienced team. Our partnership with VB Spine aligns with our mission for Spine in ANZ: 'What matters to you drives us.' We look forward to working with the Viscogliosi brothers and the VB Spine team to offer innovative solutions and valuable education to our clinicians." Transition highlights All current spinal implant SKUs remain available through LifeHealthcare with no service interruption. Surgeons and hospitals will continue to work with their local LifeHealthcare representatives. VB Spine plans to attend Deformity Down Under (DDU) in Brisbane, which began as a surgeon-led initiative to foster collaboration, share knowledge, and improve outcomes in spine surgery. Forward-looking statements Certain statements in this release are forward-looking and are based on current expectations, forecasts, and assumptions. Actual results may differ materially due to regulatory, commercial, and operational risks. VB Spine disclaims any obligation to update forward-looking statements except as required by law. Transaction financing Viscogliosi Brothers, LLC and Viscogliosi Brothers Watermark Holdings LLC are equity investors in VB Spine. About VB Spine VB Spine LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at About LifeHealthcare Distribution Pty Ltd (Australia) and LifeHealthcare Ltd (New Zealand) LifeHealthcare, an EBOS MedTech company, is committed to providing patients in Australia and New Zealand with access to world-class medical devices and technology. Our goal is to ensure the long-term economic sustainability of the healthcare system. We offer a diverse range of products across various channels for surgical intervention, including but not limited to therapeutic areas such as Spine and Enabling Technology, Orthopaedics (Reconstruction, Extremities, and Regenerative Medicine), Plastics and Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic Surgery, and Neurosurgery, among others. For more information about LifeHealthcare, please visit or About Viscogliosi Brothers Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others. For more information, visit About Viscogliosi Brothers Watermark Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit View source version on Contacts For media inquiries only: vbspinecommunications@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
2 hours ago
- Forbes
Agentic AI Meets Continuous Threat Exposure Management
Cybersecurity leaders have long wrestled with an increasingly urgent question: how do you continuously quantify and manage cyber risk in real time — at scale, and in business terms? The stakes have never been higher. Cyberattacks are accelerating in sophistication, attack surfaces are growing more dynamic, and regulators and boards are demanding clarity and accountability. Despite the intense focus on cybersecurity, traditional approaches to cyber risk remain too static, too fragmented and often too opaque. Even Continuous Threat Exposure Management — an emerging framework for real-time exposure visibility — often falls short when implemented with legacy architectures. The reason? Without autonomous intelligence, even 'continuous' systems can't keep up with the pace of threats. Agentic AI offers a possible solution: autonomous systems made up of multiple specialized agents that reason, act and adapt on their own. These architectures are now gaining traction in cybersecurity — and nowhere more significantly than in CTEM. Cyber Risk That Thinks for Itself Agentic AI represents a shift from traditional automation toward contextual, autonomous reasoning. Rather than scripting responses or aggregating alerts, agentic systems simulate attack paths, evaluate business impact and adapt their actions in real time. The result is more than efficiency — it's relevance. This is particularly compelling in CTEM, where traditional tools may generate volumes of data but struggle to prioritize what matters. CVSS scores and black-box risk models rarely capture real-world exploitability or business criticality. In contrast, agentic AI systems are being designed to triage and respond to exposures with full awareness of the organizational context. 'Agentic AI may provide the scale and immediacy of action required to deal with overwhelming volumes of data and response actions to get a handle on some of security's most difficult challenges,' said Scott Crawford, research director for information security at 451 Research, part of S&P Global Market Intelligence. 'But it will ultimately be a means to an end.' Safe, a company that began with Cyber Risk Quantification, has recently pushed this concept forward with a fully autonomous CTEM platform powered by agentic AI. According to CEO Saket Modi, 'Traditional CTEM platforms often drown teams in findings. Safe flips that model. Our Agentic AI doesn't just aggregate alerts — it reasons.' The platform uses AI agents that specialize in tasks like zero-day detection, compliance mapping and financial impact analysis. These agents operate in parallel and feed decisions back into automated workflows, creating a system that is not only reactive but strategic. From Strategy to Signal Fidelity Safe's announcement of a $70 million Series C funding round this week is notable not just for the capital raised, but for what it signals: investor confidence in a shift from dashboard-based risk awareness to intelligence-led, autonomous defense. The company's journey has taken it from CRQ to Third-Party Risk Management and now to CTEM. The common thread is a unified Agentic AI engine that drives reasoning across domains. 'Each product — CRQ, TPRM, CTEM — serves a distinct function, but they're powered by a shared data foundation,' said Modi. 'Together, they close the loop: from knowing your risk to prioritizing what matters to fixing it.' While Safe's approach is unique in execution, it highlights a broader industry movement toward convergence. Risk quantification, exposure management and remediation workflows are no longer isolated. The goal is a closed-loop system that acts continuously and contextually — without human bottlenecks. Shaping Security's Next Investment Frontier As more organizations explore intelligent automation in risk management, they're likely to encounter a broader question: how do we align security operations with business outcomes? Crawford notes, 'Uniting these two overall areas of investment is likely key to shaping many security technologies in the near future, and we expect to see significant investment in both going forward.' That dual focus — speed and strategy, data and decisions — is already informing the evolution of agentic AI platforms. As cybersecurity funding shifts toward solutions that offer defensible autonomy and strategic value, platforms that unify CTEM with CRQ and TPRM may become the new baseline. From Noise to Navigation Agentic AI is reshaping CTEM from a monitoring function into an engine of real-time cyber resilience. Platforms like Safe's demonstrate what's possible when reasoning agents replace black-box scores and fragmented tools. But the implications are broader than any one company: cybersecurity is transitioning into an era where exposure management is not only continuous — it's intelligent. The CISO of the future won't just ask 'How secure are we?' They'll ask, 'What are we doing about it — and why?' Executed properly, agentic AI may enable companies to answer this question with context in real time — and aligned with business priorities.
